Omega Therapeutics, Inc. (OMGA)
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-regulate the expression of HNF4a, a transcriptional master regulator as a potential way to restore liver-cell function in patients suffering from chronic liver diseases; to control the expression of genes that have been strongly linked to cell-growth inhibition in patients with diabetes and other conditions to restore the capacity for corneal regeneration; to down-regulate expression of the CXCL1, 2, 3, and IL-8 gene cluster; to control expression of genes implicated in patients with idiopathic pulmonary fibrosis to halt or reverse disease progression and improve disease outcomes; to down-regulate the expression of SFRP1, a protein that inhibits hair growth; and to treat non-small cell lung cancer and small cell lung cancer. It is also developing OTX-2002 to down-regulate c-Myc, an oncogene. The company was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
$73.36M
Mr. Mahesh Karande
79.00
Cambridge, MA
Jul 30, 2021
-0.94
$-1.42
3.14
3.71
-4,224.30%
-0.96
1.10
40.43
3.44
-48.05%
-95.99%
Similar stocks (11)
Structure Therapeutics Inc.
GPCR
Olema Pharmaceuticals, Inc.
OLMA
Eliem Therapeutics, Inc.
ELYM
Larimar Therapeutics, Inc.
LRMR
PepGen Inc.
PEPG
Compass Therapeutics, Inc.
CMPX
Nuvectis Pharma, Inc.
NVCT
MediciNova, Inc.
MNOV
PMV Pharmaceuticals, Inc.
PMVP
Aerovate Therapeutics, Inc.
AVTE
Cadrenal Therapeutics, Inc.
CVKD
ETF Exposure (8)
iShares Micro-Cap ETF
IWC
0.00913%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (11)
Structure Therapeutics Inc.
GPCR
Olema Pharmaceuticals, Inc.
OLMA
Eliem Therapeutics, Inc.
ELYM
Larimar Therapeutics, Inc.
LRMR
PepGen Inc.
PEPG
Compass Therapeutics, Inc.
CMPX
Nuvectis Pharma, Inc.
NVCT
MediciNova, Inc.
MNOV
PMV Pharmaceuticals, Inc.
PMVP
Aerovate Therapeutics, Inc.
AVTE
Cadrenal Therapeutics, Inc.
CVKD
ETF Exposure (8)
iShares Micro-Cap ETF
IWC
0.00913%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%